Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 69201 - 69225 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Sertraline	Approved Investigational	LSS	4047	upregulated	Sertraline results in increased expression of LSS mRNA	21q22.3	A20438 A20646
Sertraline	Approved Investigational	MAP3K13	9175	upregulated	Sertraline results in increased expression of MAP3K13 mRNA	3q27.2	A24190
Sertraline	Approved Investigational	MAP3K8	1326	upregulated	Sertraline results in increased expression of MAP3K8 mRNA	10p11.23	A24190
Sertraline	Approved Investigational	MAP4K4	9448	downregulated	Sertraline results in decreased expression of MAP4K4 mRNA	2q11.2	A24190
Sertraline	Approved Investigational	MAPK8IP3	23162	upregulated	Sertraline results in increased expression of MAPK8IP3 mRNA	16p13.3	A24190
Sertraline	Approved Investigational	MYC	4609	upregulated	Sertraline results in increased expression of MYC mRNA	8q24.21	A24190
Sertraline	Approved Investigational	NFE2L2	4780	upregulated	Sertraline results in increased expression of NFE2L2 mRNA	2q31.2	A24190
Sertraline	Approved Investigational	NFKB1	4790	upregulated	Sertraline results in increased expression of NFKB1 mRNA	4q24	A24190
Sertraline	Approved Investigational	NFKB2	4791	upregulated	Sertraline results in increased expression of NFKB2 mRNA	10q24.32	A24190
Sertraline	Approved Investigational	NR0B2	8431	upregulated	Sertraline results in increased expression of NR0B2 mRNA	1p36.11	A20438
Sertraline	Approved Investigational	NUPR1	26471	upregulated	Sertraline results in increased expression of NUPR1 mRNA	16p11.2	A20438 A20646
Sertraline	Approved Investigational	PHYH	5264	upregulated	Sertraline results in increased expression of PHYH mRNA	10p13	A20438
Sertraline	Approved Investigational	PPP1R15A	23645	upregulated	Sertraline results in increased expression of PPP1R15A mRNA	19q13.2	A24190
Sertraline	Approved Investigational	PTGS2	5743	downregulated	Sertraline results in decreased expression of PTGS2 mRNA	1q31.1	A23578
Sertraline	Approved Investigational	RBX1	9978	downregulated	Sertraline results in decreased expression of RBX1 mRNA	22q13.2	A24190
Sertraline	Approved Investigational	RELB	5971	upregulated	Sertraline results in increased expression of RELB mRNA	19q13.32	A24190
Sertraline	Approved Investigational	RPS6KA3	6197	downregulated	Sertraline results in decreased expression of RPS6KA3 mRNA	Xp22.12	A24190
Sertraline	Approved Investigational	SEC61G	23480	downregulated	Sertraline results in decreased expression of SEC61G mRNA	7p11.2	A24190
Sertraline	Approved Investigational	SERPINA3	12	upregulated	Sertraline results in increased expression of SERPINA3 mRNA	14q32.13	A20438 A20646
Sertraline	Approved Investigational	SKP1	6500	downregulated	Sertraline results in decreased expression of SKP1 mRNA	5q31.1	A24190
Sertraline	Approved Investigational	SLC2A3	6515	downregulated	Sertraline results in decreased expression of SLC2A3 mRNA	12p13.31	A20438 A20646
Sertraline	Approved Investigational	SSR2	6746	upregulated	Sertraline results in increased expression of SSR2 mRNA	1q22	A24190
Sertraline	Approved Investigational	STAT3	6774	downregulated	Sertraline results in decreased expression of STAT3 mRNA	17q21.2	A23578
Sertraline	Approved Investigational	STMN1	3925	downregulated	Sertraline results in decreased expression of STMN1 mRNA	1p36.11	A24190
Sertraline	Approved Investigational	SYVN1	84447	upregulated	Sertraline results in increased expression of SYVN1 mRNA	11q13.1	A24190

Displaying entries 69201 - 69225 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability